Search
News
Prominent Thoracic Surgeon to Lead New Division of Thoracic Surgery at UCSF
Johannes R. Kratz, MD, has been appointed as the inaugural Chief of UCSF’s Division of Thoracic Surgery, one of the leading, academic robotic thoracic surgery programs in the western United States.
Video
High Risk for Breast Cancer: Methods and Schedules to Ensure Optimal Screening
Hematologist-oncologist Elham Vosoughi, MD, starts with an update on breast cancer stats, noting that incidence in the United States is increasing by 1% every year – with an even sharper rise for women under 50.
Video
Making Sense of MGUS: How to Detect Plasma Cell Disorders and Assess Associated Risks
Affecting up to 5% of the U.S. population (and increasingly common with age), monoclonal gammopathy of undetermined significance (MGUS) raises the risk of multiple myeloma, but – as its full name suggests – it can be hard to say by how much.
News
UCSF Awarded $12M Research Grant to Improve Cancer Outcomes
SPORE Grant from National Cancer Institute provides resources for translational research into genomic, biochemical, and environmental drivers of cancers outcomes.
News
‘Every Time I Relapsed, There Would Be a New Course of Therapy’
He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.
News
Novel Immunotherapy Combination Destroys Colorectal Liver Metastases
UCSF researchers disrupt tumor immune environment with LIGHT/anti-CTLA-4 therapy in preclinical models.
News
Improving Management and Treatment of Thyroid Cancer
UCSF’s Julie Ann Sosa, MD, co-led an international task force establishing new clinical guidelines for the management of differentiated thyroid cancer.
News
Sneaky Senescent Cells That Resist Cancer Treatment Can Provide Druggable Lung Cancer Target
Senescent fibroblasts are aging cells that no longer divide and protect against tumor development.
News
Engineered Receptors Help the Immune System Home in on Cancer
Most cancer treatments – from chemotherapies to engineered immune cells – have a host of side effects, in large part because they affect healthy cells in the body at the same time as targeting tumor cells
News
Felix Feng, Giant in the Field of Prostate Cancer, Dies at 48
“Felix Feng was an exceptional scientist – a once-in-a-generation scientist – and his staggering intellect and scientific insights led to his remarkable scientific accomplishments,"
News
How This Cancer Drug Could Make Radiation a Slam Dunk Therapy
UCSF scientists combine a precision drug therapy with an antibody and radiation to eliminate tumors without causing side effects.
News
Prostate Cancer Study: More Health Benefits from Plant-Based Diet
Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts and olive oil, according to new research by UC San Francisco.
News
Prioritizing Organ Preservation for Rectal Cancer Patients
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required.
News
Katherine Van Loon Named Editor-in-Chief of JCO Global Oncology
Katherine Van Loon, MD, MPH, has been appointed as the next editor-in-chief of JCO Global Oncology (JCO GO), an American Society of Clinical Oncology (ASCO) journal.
News
Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV
Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
News
Powerful New Mini Microscopic Will Enable Precision Cancer Surgery
UCSF’s Mekhail Anwar wins an up to $15 million award from ARPA-H to develop a next-generation miniature scanner powerful enough to detect individual cancer cells during surgery.
News
UCSF Radiation Oncologist Honored for Prostate Cancer Care and Research
American Society of Radiation Oncology celebrates Mack Roach, III, MD, for profound impact on patient treatment and leadership in cancer disparities treatment outcomes.
News
Study Finds Significant Chemical Exposures in Women With Cancer
In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher levels of these chemicals in their bodies.
News
Inclusion of New Risk Factors Can Improve Prediction of Invasive Breast Cancer
UCSF researchers update Breast Cancer Surveillance Consortium model to account for BMI and other familial risk factors.
News
UCSF Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers.
News
Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities
While regular screenings may decrease the chance of diagnosis of advanced breast cancer in some women and lead to a 20% reduction in breast cancer mortality, other women will be diagnosed with advanced breast cancer despite screening at regular intervals.
News
Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Immune checkpoint inhibitors have demonstrated limited efficacy in treating prostate cancer. Efforts to improve outcomes with combination therapies have mostly failed to demonstrate improvements compared to other types of cancer.
News
Repurposing a Diabetes Medication to Prime CAR T Cancer Targets
By combining CAR T therapy with diabetes drugs, UCSF researchers improve anti-tumor activity in urothelial cancer cells.
News
UCSF Health Reaches 15,000 Robotic Surgeries
UCSF Health has the busiest robotic surgery program in the UC health system and is the leading academic medical institution for robotic surgeries in the western U.S.
